A type III effectiveness-implementation hybrid evaluation of a multicomponent patient navigation strategy for advanced-stage Kaposi’s sarcoma: protocol

BACKGROUND: For people with advanced-stage Kaposi’s sarcoma (KS), a common HIV-associated malignancy in sub-Saharan Africa, mortality is estimated to be 45% within 2 years after KS diagnosis, despite increasingly wide-spread availability of antiretroviral therapy and chemotherapy. For advanced-stage...

Descripción completa

Detalles Bibliográficos
Autores principales: Collier, Sigrid, Semeere, Aggrey, Byakwaga, Helen, Laker-Oketta, Miriam, Chemtai, Linda, Wagner, Anjuli D., Bassett, Ingrid V., Wools-Kaloustian, Kara, Maurer, Toby, Martin, Jeffrey, Kiprono, Samson, Freeman, Esther E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102240/
https://www.ncbi.nlm.nih.gov/pubmed/35562783
http://dx.doi.org/10.1186/s43058-022-00281-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102240/
https://www.ncbi.nlm.nih.gov/pubmed/35562783
http://dx.doi.org/10.1186/s43058-022-00281-7

Ejemplares similares